Review





Similar Products

99
Bruker Corporation d8 advance x ray diffractometer
Structural characterization of HC. (A) Schematic illustration of the synthesis of HC. (B, C) TEM images of Cu 5.4 O and HC. (D) <t>Energy-dispersive</t> <t>X-ray</t> spectroscopy (EDS) mapping images of C, N, Cu and O for HC. (E) Zeta potentials and hydrodynamic size distribution, and (F) XRD analysis of Cu 5.4 O, HAs and HC. (G, H) XPS spectra of Cu 2p of Cu 5.4 O and HC. (I) X-ray-induced Auger electron spectroscopy (XAES) spectra of the Cu 5.4 O. (J) Size stability of HC in different solvents (Water, PBS, FBS, DMEM) on days 3, 5, and 7 at a concentration of 200 μg/mL, with a sample size of n = 3 (mean ± SD). (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).
D8 Advance X Ray Diffractometer, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/d8 advance x ray diffractometer/product/Bruker Corporation
Average 99 stars, based on 1 article reviews
d8 advance x ray diffractometer - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

86
Malvern Panalytical panalytical aeris diffractometer
Structural characterization of HC. (A) Schematic illustration of the synthesis of HC. (B, C) TEM images of Cu 5.4 O and HC. (D) <t>Energy-dispersive</t> <t>X-ray</t> spectroscopy (EDS) mapping images of C, N, Cu and O for HC. (E) Zeta potentials and hydrodynamic size distribution, and (F) XRD analysis of Cu 5.4 O, HAs and HC. (G, H) XPS spectra of Cu 2p of Cu 5.4 O and HC. (I) X-ray-induced Auger electron spectroscopy (XAES) spectra of the Cu 5.4 O. (J) Size stability of HC in different solvents (Water, PBS, FBS, DMEM) on days 3, 5, and 7 at a concentration of 200 μg/mL, with a sample size of n = 3 (mean ± SD). (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).
Panalytical Aeris Diffractometer, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/panalytical aeris diffractometer/product/Malvern Panalytical
Average 86 stars, based on 1 article reviews
panalytical aeris diffractometer - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Philips Healthcare x pert pro super x ray diffractometer
Structural characterization of HC. (A) Schematic illustration of the synthesis of HC. (B, C) TEM images of Cu 5.4 O and HC. (D) <t>Energy-dispersive</t> <t>X-ray</t> spectroscopy (EDS) mapping images of C, N, Cu and O for HC. (E) Zeta potentials and hydrodynamic size distribution, and (F) XRD analysis of Cu 5.4 O, HAs and HC. (G, H) XPS spectra of Cu 2p of Cu 5.4 O and HC. (I) X-ray-induced Auger electron spectroscopy (XAES) spectra of the Cu 5.4 O. (J) Size stability of HC in different solvents (Water, PBS, FBS, DMEM) on days 3, 5, and 7 at a concentration of 200 μg/mL, with a sample size of n = 3 (mean ± SD). (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).
X Pert Pro Super X Ray Diffractometer, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/x pert pro super x ray diffractometer/product/Philips Healthcare
Average 86 stars, based on 1 article reviews
x pert pro super x ray diffractometer - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Philips Healthcare x pert pro diffractometer
Structural characterization of HC. (A) Schematic illustration of the synthesis of HC. (B, C) TEM images of Cu 5.4 O and HC. (D) <t>Energy-dispersive</t> <t>X-ray</t> spectroscopy (EDS) mapping images of C, N, Cu and O for HC. (E) Zeta potentials and hydrodynamic size distribution, and (F) XRD analysis of Cu 5.4 O, HAs and HC. (G, H) XPS spectra of Cu 2p of Cu 5.4 O and HC. (I) X-ray-induced Auger electron spectroscopy (XAES) spectra of the Cu 5.4 O. (J) Size stability of HC in different solvents (Water, PBS, FBS, DMEM) on days 3, 5, and 7 at a concentration of 200 μg/mL, with a sample size of n = 3 (mean ± SD). (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).
X Pert Pro Diffractometer, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/x pert pro diffractometer/product/Philips Healthcare
Average 86 stars, based on 1 article reviews
x pert pro diffractometer - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

99
Bruker Corporation bruker d8 advance diffractometer
Structural characterization of HC. (A) Schematic illustration of the synthesis of HC. (B, C) TEM images of Cu 5.4 O and HC. (D) <t>Energy-dispersive</t> <t>X-ray</t> spectroscopy (EDS) mapping images of C, N, Cu and O for HC. (E) Zeta potentials and hydrodynamic size distribution, and (F) XRD analysis of Cu 5.4 O, HAs and HC. (G, H) XPS spectra of Cu 2p of Cu 5.4 O and HC. (I) X-ray-induced Auger electron spectroscopy (XAES) spectra of the Cu 5.4 O. (J) Size stability of HC in different solvents (Water, PBS, FBS, DMEM) on days 3, 5, and 7 at a concentration of 200 μg/mL, with a sample size of n = 3 (mean ± SD). (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).
Bruker D8 Advance Diffractometer, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bruker d8 advance diffractometer/product/Bruker Corporation
Average 99 stars, based on 1 article reviews
bruker d8 advance diffractometer - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

86
Dandong Yichuang Pharmaceutical Co Ltd dx 1000 x ray diffractometer
Structural characterization of HC. (A) Schematic illustration of the synthesis of HC. (B, C) TEM images of Cu 5.4 O and HC. (D) <t>Energy-dispersive</t> <t>X-ray</t> spectroscopy (EDS) mapping images of C, N, Cu and O for HC. (E) Zeta potentials and hydrodynamic size distribution, and (F) XRD analysis of Cu 5.4 O, HAs and HC. (G, H) XPS spectra of Cu 2p of Cu 5.4 O and HC. (I) X-ray-induced Auger electron spectroscopy (XAES) spectra of the Cu 5.4 O. (J) Size stability of HC in different solvents (Water, PBS, FBS, DMEM) on days 3, 5, and 7 at a concentration of 200 μg/mL, with a sample size of n = 3 (mean ± SD). (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).
Dx 1000 X Ray Diffractometer, supplied by Dandong Yichuang Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dx 1000 x ray diffractometer/product/Dandong Yichuang Pharmaceutical Co Ltd
Average 86 stars, based on 1 article reviews
dx 1000 x ray diffractometer - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

99
Bruker Corporation d2 phaser diffractometer
Structural characterization of HC. (A) Schematic illustration of the synthesis of HC. (B, C) TEM images of Cu 5.4 O and HC. (D) <t>Energy-dispersive</t> <t>X-ray</t> spectroscopy (EDS) mapping images of C, N, Cu and O for HC. (E) Zeta potentials and hydrodynamic size distribution, and (F) XRD analysis of Cu 5.4 O, HAs and HC. (G, H) XPS spectra of Cu 2p of Cu 5.4 O and HC. (I) X-ray-induced Auger electron spectroscopy (XAES) spectra of the Cu 5.4 O. (J) Size stability of HC in different solvents (Water, PBS, FBS, DMEM) on days 3, 5, and 7 at a concentration of 200 μg/mL, with a sample size of n = 3 (mean ± SD). (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).
D2 Phaser Diffractometer, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/d2 phaser diffractometer/product/Bruker Corporation
Average 99 stars, based on 1 article reviews
d2 phaser diffractometer - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

99
Bruker Corporation d2 phaser x ray diffractometer
Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. <t>(e)</t> <t>X-ray</t> diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.
D2 Phaser X Ray Diffractometer, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/d2 phaser x ray diffractometer/product/Bruker Corporation
Average 99 stars, based on 1 article reviews
d2 phaser x ray diffractometer - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

86
Malvern Panalytical panalytical x pert diffractometer operating
Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. <t>(e)</t> <t>X-ray</t> diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.
Panalytical X Pert Diffractometer Operating, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/panalytical x pert diffractometer operating/product/Malvern Panalytical
Average 86 stars, based on 1 article reviews
panalytical x pert diffractometer operating - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


Structural characterization of HC. (A) Schematic illustration of the synthesis of HC. (B, C) TEM images of Cu 5.4 O and HC. (D) Energy-dispersive X-ray spectroscopy (EDS) mapping images of C, N, Cu and O for HC. (E) Zeta potentials and hydrodynamic size distribution, and (F) XRD analysis of Cu 5.4 O, HAs and HC. (G, H) XPS spectra of Cu 2p of Cu 5.4 O and HC. (I) X-ray-induced Auger electron spectroscopy (XAES) spectra of the Cu 5.4 O. (J) Size stability of HC in different solvents (Water, PBS, FBS, DMEM) on days 3, 5, and 7 at a concentration of 200 μg/mL, with a sample size of n = 3 (mean ± SD). (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).

Journal: Bioactive Materials

Article Title: Smart microenvironment-adaptive nanocatalytic hydrogel for sequential antibacterial, anti-inflammatory, and regenerative therapy of biofilm-infected wounds

doi: 10.1016/j.bioactmat.2026.02.043

Figure Lengend Snippet: Structural characterization of HC. (A) Schematic illustration of the synthesis of HC. (B, C) TEM images of Cu 5.4 O and HC. (D) Energy-dispersive X-ray spectroscopy (EDS) mapping images of C, N, Cu and O for HC. (E) Zeta potentials and hydrodynamic size distribution, and (F) XRD analysis of Cu 5.4 O, HAs and HC. (G, H) XPS spectra of Cu 2p of Cu 5.4 O and HC. (I) X-ray-induced Auger electron spectroscopy (XAES) spectra of the Cu 5.4 O. (J) Size stability of HC in different solvents (Water, PBS, FBS, DMEM) on days 3, 5, and 7 at a concentration of 200 μg/mL, with a sample size of n = 3 (mean ± SD). (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).

Article Snippet: X-ray diffraction (XRD) patterns were conducted on a Bruker D8 ADVANCE X-ray diffractometer using Cu-Kα radiation (λ = 1.5418 Å).

Techniques: Spectroscopy, Concentration Assay

Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. (e) X-ray diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.

Journal: International Journal of Pharmaceutics: X

Article Title: Gold-incorporated hyaluronic acid nanoparticles enhance ablative radiotherapy efficacy in lung cancer

doi: 10.1016/j.ijpx.2025.100480

Figure Lengend Snippet: Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. (e) X-ray diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.

Article Snippet: Powder X-ray diffraction (XRD) patterns of SN38, HA NP, and Au/HA NP were recorded using a D2 PHASER X-ray diffractometer (Bruker Analytical X-Ray Solutions, Madison, WI, USA) equipped with a Cu Kα radiation source (λ = 1.5418 Å).

Techniques: Synthesized, Lyophilization, Transmission Assay, Electron Microscopy, Staining, Imaging, Zeta Potential Analyzer, Electrophoresis, MANN-WHITNEY, Modification, Expressing, Flow Cytometry